NLRP3 Inflammasome in Polycystic Ovary Syndrome: Pathogenic Mechanisms and Therapeutic Potential
Medicine Insights · 2026
DOI: 10.70088/b5qj9931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicine Insights, 2026. Verfasst von Simin Yu und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a polygenic and multifactorial reproductive endocrine disorder, with chronic low-grade inflammation recognized as a contributing factor in its pathogenesis. The NOD-like receptor protein 3 (NLRP3) inflammasome is a multiprotein complex within the innate immune system whose activation leads to the production of inflammatory cytokines and inflammatory factors. A growing body of evidence indicates that the NLRP3 inflammasome plays a critical role in the pathophysiology of PCOS. This review summarizes the multifaceted roles of the NLRP3 inflammasome in the pathogenesis and treatment of PCOS, aiming to provide novel insights and directions for further investigation into the pathogenic mechanisms and clinical management of PCOS.
Zitieren
APA
Yu, S., & Su, T. (2026). NLRP3 Inflammasome in Polycystic Ovary Syndrome: Pathogenic Mechanisms and Therapeutic Potential. Medicine Insights. https://doi.org/10.70088/b5qj9931
Vancouver
Yu S, Su T. NLRP3 Inflammasome in Polycystic Ovary Syndrome: Pathogenic Mechanisms and Therapeutic Potential. Medicine Insights. 2026. doi:10.70088/b5qj9931
BibTeX
@article{Yu2026,
author = {Yu, Simin and Su, Tongye},
title = {NLRP3 Inflammasome in Polycystic Ovary Syndrome: Pathogenic Mechanisms and Therapeutic Potential},
journal = {Medicine Insights},
year = {2026},
doi = {10.70088/b5qj9931}
}
EUVIMED